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Objective. To determine whether structured assessment of outpatient endometrial biopsies decreases the number of inconclusive
samples. Design. Retrospective cohort study. Setting. Single hospital pathology laboratory. Population. Endometrial biopsy samples
of 66womenwith postmenopausal bleeding, collected during the usual diagnostic work-up and assessed as insufficient for a reliable
histological diagnosis.Methods.Endometrial biopsy samples were requested from the pathology laboratories.The retrieved samples
were systematically reassessed by a single pathologist specialized in gynecology. Main Outcome Measure. Disagreement between
initial assessment and conclusion after structured reassessment. Results.We retrieved 36 of 66 endometrial biopsy samples from six
different pathology laboratories. Structured reassessment of the retrieved samples by a single pathologist specialized in gynecology
did not change the conclusion in 35 of the 36 samples. The remaining sample contained a large amount of endometrial tissue and
the diagnosis at reassessment was endometrial hyperplasia without atypia. All other samples contained insufficient material for a
reliable diagnosis. Conclusion. A structured reassessment of endometrial biopsies samples, which were classified as inconclusive
due to insufficient material, did not change the conclusion. Although it might be helpful for pathologists to have diagnostic criteria
for adequacy and/or inadequacy of an endometrial biopsy sample, the gain in efficiency is likely to be small.
1. Introduction
Patients with postmenopausal bleeding (PMB) are at risk for
endometrial carcinoma and therefore PMB warrants further
investigation. Histological endometrial assessment is indi-
cated when a patient presents with postmenopausal bleeding
and an increased endometrial thickness on transvaginal
sonography (TVS) [1, 2]. Outpatient endometrial biopsy is
the least invasive technique to obtain material for histo-
logical assessment. Endometrial biopsies have a very high
sensitivity for diagnosing an endometrial (pre)malignancy in
postmenopausal women (95%) [3]. Furthermore, performing
an endometrial biopsy in women with PMB and an increased
endometrial thickness is the most cost-effective strategy [4].
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Figure 1: Flowchart of women with postmenopausal bleeding included in the original prospective cohort study.
Yet, 7–68% of outpatient endometrial biopsy samples
are inconclusive because the amount of tissue obtained is
insufficient for a reliable histopathological diagnosis [5–8].
In such cases, a more invasive hysteroscopy or dilatation and
curettage (D&C) is necessary in order to rule out endometrial
carcinoma or atypical hyperplasia, which is present in 6% of
these women [7]. The high failure rate due to inconclusive
endometrial biopsiesmight affect the cost-effectiveness of the
diagnostic work-up.
Among pathologists considerable disagreement exists
about what constitutes an adequate endometrial biopsy
sample. A questionnaire sent to all members of the British
Association of Gynecological Pathologists and participants
in the National Gynecological Pathology External Quality
Assessment Scheme in the UK revealed that 88.5% of the
respondents would think that criteria for adequacy and/or
inadequacywould be useful [9]. Such guidelines are at present
not available. This results in a diagnosis that is influenced
by subjectivity, with a high interobserver variability between
pathologists.
The objective of the current study was to determine
whether structured assessment of outpatient endometrial
biopsy samples with strict criteria decreases the amount of
inconclusive samples due to insufficient material.
2. Material and Methods
Material collected during the diagnostic work-up of women
participating in a previous prospective cohort study on PMB
was used for the present study [7]. Details of the cohort
are presented in the original publication. In short, data on
all women presenting with PMB in seven teaching hospitals
and one university hospital in Netherlands, between January
2001 and June 2003, were prospectively collected to evaluate
the diagnostic work-up in women with PMB in Netherlands
[7]. During the study period, 516 women with PMB were
seen in the outpatient clinic. If the endometrial thickness
measured more than 4mm and in case of an unclear endo-
metrial thickness, an endometrial biopsy was indicated.
In 403 of those women, an outpatient endometrial biopsy
was performed. In this study there was an inconclusive
endometrial biopsy sample due to insufficient tissue in 66 of
the 403 women. All 66 women were subsequently evaluated
with hysteroscopy or D&C and in 4 women (6%) an endome-
trial (pre)malignancy was diagnosed. The 66 cases with an
inconclusive endometrial biopsy in the prospective cohort
were used for the current study (Figure 1).
The endometrial biopsy samples were requested from the
pathology laboratories of the eight hospitals. Based on two
reports on the assessment of endometrial biopsy samples,
we proposed items for a structured assessment (Table 1) [9,
10]. The material was systematically scored on the items
“estimated amount of material” and “quality of material.”The
endometrial biopsy samples were systematically reassessed
by a single pathologist specialized in gynecology (AW). The
pathologist knew that it was a reassessment of previously
nondiagnostic endometrial biopsy samples but was blinded
to the final diagnosis in the original cohort study. If the quality
of the slides was decreased due to their age, new HE stained
slides were made; paraffin blocks were always at hand. The
study was reviewed and approved by the institutional review
board.
2.1. Statistical Analysis. Statistical analysis was performed
with the PASW statistics 18.0 package (SPSS, Inc., Somers,
NY, USA). Depending on the distribution, continuous vari-
ables were presented as mean ± standard deviation or as
median and interquartile range, and differences between
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Table 1: Items for assessment of the adequacy of an endometrial
biopsy sample.
Items
Estimated amount of
material
No material
<0.5 cm2
0.5–1.0 cm2
1.0–2.0 cm2
>2.0 cm2
Quality of material
No endometrial tissue
Only superficial endometrial tissue
A large amount of endometrial tissue
groups tested with an independent samples 𝑡-test or a Mann-
Whitney𝑈 test. Categorical data were presented as𝑁 (%) and
groups compared using a Chi-square test.
3. Results
Wewere able to retrieve endometrial biopsy samples from 36
(55%) women from six different pathology laboratories. Two
hospitals did not respond to our request to send material.
Pathology laboratories that did not respond to the initial
request were contacted by phone once. Afterwards, no further
efforts were made to obtain the samples.
In endometrial biopsy samples from 29 (80.5%) of the
36 women, no endometrial tissue was found. The pathol-
ogist described just mucus, blood, or superficial columnar
epithelium. In endometrial biopsy samples from six (16.7%)
women, superficial endometrium was found, with only one
very small strip of endometrial stroma, and therefore these
samples were also inconclusive. In one (2.89%) endometrial
biopsy sample, the amount of endometrium present was suf-
ficient for assessment, and the diagnosis simple endometrial
hyperplasia without atypia was established on this sample.
The reassessment for all 36 women with the macroscopic
description is reported in Table 2.
Characteristics of women from whom no material was
received were compared to those of women with reassessed
samples; no differences were found (Table 3). All samples
of women that were initially inconclusive but diagnosed
with endometrial (pre)malignancy at subsequent testingwere
available for reassessment.
4. Discussion
A structured reassessment of endometrial biopsy samples
that were initially classified as inconclusive due to insufficient
material did not change the conclusion in the majority of
cases. To our knowledge, there are no previous reports on
the attempt to increase the diagnostic efficiency of outpatient
endometrial biopsy by structured assessment.
In women with PMB and an endometrial thickness more
than 4mm or an unclear endometrial thickness and an
inconclusive outpatient endometrial biopsy, an endometrial
(pre)malignancy is found in 6%.Therefore, thesewomen can-
not be reassured without further, more invasive, diagnostics
[7].
Reviewing hospital protocols revealed that a protocol on
standardized sampling methods was not available in any hos-
pital, let alone the recommendations on using a tenaculum,
entering the uterine cavity more than once, or the use of
analgesia in painful procedures.
The strength of our study is that all endometrial biopsy
samples were assessed by one pathologist specialized in
gynecology who was blinded to the definite diagnosis. Yet,
our study is limited by the fact that only 55% of the requested
endometrial biopsy samples were retrieves. It is however
unlikely that a complete response would have changed
our conclusions. Only one of the 36 available endometrial
biopsy samples was considered diagnostic at reassessment
within this selection, and second, all samples of women that
were initially inconclusive but diagnosed with endometrial
(pre)malignancy at subsequent testing were available for
reassessment. Characteristics of women from whom no
material was received were compared to those of women
with reassessed samples; no differences were found. Another
limitation of our study is that the pathologist perform-
ing the reassessment knew that the endometrial biopsy sam-
ples were initially assessed as inconclusive, which potentially
leads to a biased interpretation at reassessment. Performing
a prospective cohort study where all endometrial biopsy
samples are assessed with structured criteria during a certain
period could solve this. The amount of insufficient samples
could be compared to the amount of insufficient samples
in a previous period without structured pathology assess-
ment.
In 2005 Phillips andMcCluggage reported on a question-
naire among 61 pathologists in the UK. Most respondents
felt that it would be useful if criteria for adequacy and/or
inadequacy were proposed [9]. Similar criteria are already
used for the evaluation of specimen adequacy in fine needle
aspiration of thyroid nodules [11].
In the cost-effectiveness analysis by Clark et al., the
failure rate due to inconclusive endometrial biopsy samples
was 12% (95% CI 0.09–0.15) based on a systematic review [4].
In our cohort study on PMB, 66 out of 403 endometrial biop-
sies were inconclusive (16.4%). Other studies report a failure
rate of 7–68% [5–8]. The high failure rate of endometrial
biopsies might have consequences for the cost-effectiveness
of the technique.
5. Conclusions
Our findings suggest that although it might be helpful for
pathologists to have diagnostic criteria for adequacy and/or
inadequacy of an endometrial biopsy sample, the gain in
efficiency is likely to be small. We therefore think that, to
increase the effectiveness of outpatient endometrial biopsies,
the physician performing an outpatient endometrial biopsy
should try to obtain asmuchmaterial as possible tominimize
the chance of a failed biopsy. Further research should focus on
the best way to achieve this.
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Table 2: Reassessment of endometrial samples.
Patient Macroscopic Amount (cm2) Quality Diagnosis
1 5mL mucus <0.5 No endometrial tissue No diagnosis
2 Tissue 15 × 3mm <0.5 No endometrial tissue No diagnosis
3 0.5mL tissue <0.5 No endometrial tissue No diagnosis
4 Just mucus and blood <0.5 No endometrial tissue No diagnosis
5 1mL tissue <0.5 No endometrial tissue No diagnosis
6 Just mucus and blood <0.5 No endometrial tissue No diagnosis
7 Some tissue 1 to 4mm <0.5 Superficial endometrial tissue No diagnosis
8 Some white tissue <0.5 No endometrial tissue No diagnosis
9 Red/brown mucinous tissue <0.5 No endometrial tissue No diagnosis
10 Very little mucinous tissue <0.5 No endometrial tissue No diagnosis
11 Very little grey/red material <0.5 No endometrial tissue No diagnosis
12 Some grey/red tissue fragments maximum 3 cm >2.0 Large amount of endometrial tissue Hyperplasia without atypia
13 Little grey/brown material <0.5 No endometrial tissue No diagnosis
14 Hardly any material <0.5 No endometrial tissue No diagnosis
15 Very little grey/brown material <0.5 No endometrial tissue No diagnosis
16 1mL mucus <0.5 No endometrial tissue No diagnosis
17 0.5mL mucus <0.5 No endometrial tissue No diagnosis
18 <0.5mL mucus <0.5 No endometrial tissue No diagnosis
19 Some tissue fragments <0.5mm <0.5 No endometrial tissue No diagnosis
20 0.5mL mucinous bloody material <0.5 No endometrial tissue No diagnosis
21 15mL mucinous material <0.5 No endometrial tissue No diagnosis
22 <0.25mL mucus <0.5 No endometrial tissue No diagnosis
23 Some mucinous fragments <0.5 Superficial endometrial tissue No diagnosis
24 0.5mL mucinous bloody material <0.5 Superficial endometrial tissue No diagnosis
25 0.5mL material <0.5 Superficial endometrial tissue No diagnosis
26 Some very small fragments <0.5 No endometrial tissue No diagnosis
27 0.5mL mucinous material <0.5 No endometrial tissue No diagnosis
28 <0.5mL mucinous material <0.5 No endometrial tissue No diagnosis
29 Three mucinous fragments 1-2mm <0.5 Superficial endometrial tissue No diagnosis
30 0.5mL mucinous material <0.5 No endometrial tissue No diagnosis
31 <0.25mL mucus <0.5 No endometrial tissue No diagnosis
32 0.25mL mucus <0.5 No endometrial tissue No diagnosis
33 <0.2mL material <0.5 No endometrial tissue No diagnosis
34 Just mucus <0.5 No endometrial tissue No diagnosis
35 0.2mL material <0.5 Superficial endometrial tissue No diagnosis
36 Mucinous material <0.5 No endometrial tissue No diagnosis
Table 3: Characteristics of women with a nondiagnostic sample, retrieved samples versus not retrieved samples.
Characteristic Material retrieved (𝑁 = 36) Material not retrieved (𝑁 = 30) 𝑃 value
Age (years)a 62.5 ± 8.7 61.9 ± 10.0 𝑃 = 0.39
Body mass index (kg/m2)a 29.1 ± 6.35 27.5 ± 4.84 𝑃 = 0.53
Endometrial thickness (mm)b 7.5 (6.0–13.5) 7.0 (6.0–10.5) 𝑃 = 0.42
Hormone therapy use 𝑛 (%)c 7 (19.4%) 7 (23.3%) 𝑃 = 0.89
Nulliparity 𝑛 (%)c 2 (5.6%) 3 (10%) 𝑃 = 0.69
Endometrial (pre)malignancy 𝑛 (%)c 4 (11.1%) 0 𝑃 = 0.03
aIndependent samples 𝑡-test, mean ± SD.
bMann-Whitney 𝑈 test, median IQR.
cChi-square.
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